04/23/2024
4:00 PM | Michaud Charles Jr (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:33 PM | Homology Medicines (Filer)
Q32 Bio Inc. (Filer)
| Form 10-K/A | |
04/04/2024
7:33 PM | ACORN BIOVENTURES, L.P. (Filed by)
Homology Medicines (Subject)
Q32 Bio Inc. (Subject)
| Form SC 13D | |
04/01/2024
8:52 PM | Atlas Venture Fund X, L.P. (Filed by)
Homology Medicines (Subject)
Q32 Bio Inc. (Subject)
| Form SC 13D | |
03/29/2024
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Homology Medicines (Subject)
Q32 Bio Inc. (Subject)
| Form SC 13G | |
03/28/2024
3:28 PM | Homology Medicines (Subject)
Q32 Bio Inc. (Subject)
| Form SC 13D | |
03/27/2024
4:35 PM | LAPORTE KATHLEEN (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/27/2024
4:36 PM | Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
Violette Shelia M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:36 PM | Morrison Jodie Pope (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:37 PM | Campagna Jason (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:39 PM | Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
Xu Diyong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:39 PM | GRAYZEL DAVID S. (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:40 PM | Iwicki Mark T (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:42 PM | Manke Isaac (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:43 PM | Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:25 PM | Lundberg Sven Ante (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:32 PM | Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
Violette Shelia M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:33 PM | Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
Thistle Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:34 PM | Kalowski Lee (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:14 PM | Lundberg Sven Ante (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:16 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting)
Atlas Venture Associates X, LLC (Reporting)
Atlas Venture Fund X, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:16 PM | Iwicki Mark T (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:17 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:18 PM | Kalowski Lee (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:20 PM | Campagna Jason (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:21 PM | LAPORTE KATHLEEN (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:22 PM | Morrison Jodie Pope (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:23 PM | Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
Xu Diyong (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:24 PM | Manke Isaac (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
4:24 PM | GRAYZEL DAVID S. (Reporting)
Homology Medicines (Issuer)
Q32 Bio Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/26/2024
8:57 PM | Homology Medicines (Filer)
Q32 Bio Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
9:23 AM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 8-K/A | |
03/15/2024
4:18 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
6:42 AM | ADAR1 Partners, LP (Filed by)
Homology Medicines (Subject)
Homology Medicines, Inc. (Subject)
| Form SCHEDULE 13G | |
03/13/2024
12:44 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form POS EX | |
03/13/2024
12:36 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 424B3 | |
03/12/2024
8:56 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
6:32 AM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
6:37 AM | Homology Medicines (Subject)
Homology Medicines, Inc. (Subject)
| Form 425 | |
02/15/2024
3:33 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
11:15 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form EFFECT | |
“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad) Central Banks Buying Gold in Record Numbers
Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). |
02/13/2024
9:11 AM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form S-4/A | |
02/12/2024
5:25 AM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form S-4/A | |
01/26/2024
7:31 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form S-4/A | |
01/05/2024
4:49 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
Michaud Charles Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:54 PM | Alloway Paul (Reporting)
Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
Michaud Charles Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
3:15 PM | Alloway Paul (Reporting)
Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
6:45 AM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
6:46 AM | Homology Medicines (Subject)
Homology Medicines, Inc. (Subject)
| Form 425 | |
11/16/2023
6:16 AM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
6:17 AM | Homology Medicines (Subject)
Homology Medicines, Inc. (Subject)
| Form 425 | |
11/14/2023
3:00 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023
4:22 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
3:44 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
Seymour Albert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:39 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
Jordan Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2023
4:29 PM | Homology Medicines (Filer)
Homology Medicines, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
6:25 PM | GILLIS STEVEN (Reporting)
Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:33 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
Patterson Matthew R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:04 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
REICIN ALISE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:09 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
Poulton Jeffrey V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:14 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
5:17 PM | Homology Medicines (Issuer)
Homology Medicines, Inc. (Issuer)
Thistle Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
